Form D — Jaguar Health, Inc.
0001193125-25-293746 · filed Nov 24, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $10,810,000
- Reported amount sold
- $10,810,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Jaguar Health, Inc.
- CIK
- 1585608
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 200 Pine St., Ste 400
San Francisco, CA 94104 - Phone
- 415-371-8300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lisa Conte · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Carol Lizak · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Steven King · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Jonathan Wolin · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
James Bochnowski · DirectorSan Francisco, CA Find on LinkedIn ↗
-
John Micek III · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Anula Jayasuriya · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Jonathan Siegel · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Pravin Chaturvedi · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗